Cargando...
AXL receptor tyrosine kinase: a possible therapeutic target in acute promyelocytic leukemia
BACKGROUND: Acute promyelocytic leukemia (APL) is a subset of acute myeloid leukemia (AML) which is characterized by the fusion of promyelocytic leukemia PML and retinoic acid receptor- alpha (RAR-alpha) genes. All-trans retinoic acid (ATRA) and/or arsenic trioxide (ATO) have resulted in durable cyt...
Guardado en:
| Publicado en: | BMC Cancer |
|---|---|
| Autores principales: | , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
BioMed Central
2021
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8210361/ https://ncbi.nlm.nih.gov/pubmed/34140003 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-021-08450-y |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|